Revolutionizing Pleural Infection Diagnosis
The Challenge of Pleural Infections.
Pleural infections, especially among immunocompromised or elderly patients, are a growing concern, with mortality rates as high as 27%.
Delayed diagnosis often leads to unnecessary antibiotic use and longer hospital stays.
Early diagnosis is critical to reduce complications and improve patient outcomes.
The solution: Molecular Culture® ID.
Molecular Culture® ID accelerates pleural infection diagnostics, identifying bacterial species in hours, not days. This breakthrough technology ensures clinicians can make informed decisions quickly, reducing the reliance on broad-spectrum antibiotics.
The Impact in Healthcare.
- Results in hours, not days.
- Identifies hundreds of bacterial species, including those missed by traditional methods.
- Reduces unnecessary antibiotic use and hospital stays.
Clinical Performance of Molecular Culture® ID.
A study of 440 pleural effusion samples shows that Molecular Culture® ID significantly outperforms traditional culture methods. With higher accuracy and faster results, the technology leads to better patient outcomes.
Molecular Culture® ID found 2.4X more positive samples and 4x more bacteria than traditional culture.
Request your Starter Kit now.
We are happy to send you a free Molecular Culture® testkit to experience the benefits in practice. Contact us with the form below.
